Skip to main content
. 1997 Sep 30;94(20):10889–10894. doi: 10.1073/pnas.94.20.10889

Table 1.

Ability of AddlE1–B7-1, AdMEM12R and AdIL12–B7-1 to induce tumor regression following a single intratumoral injection

Virus Exp. Response
None* Growth delay† Partial‡ Complete§
AddlE1–B7-1 1 0 5 0 0
(2.5 × 107) 2 1 4 0 0
3 0 5 0 0
 Total (1/15) (14/15)
AdMEM12R 1 1 4 0 0
(2.5 × 107) 2 1 4 0 0
3 0 5 0 0
 Total (2/15) (13/15)
AddlE1–B7-1 1 0 2 1 2
AdMEM12R 2 0 4 0 1
(2.5 × 107)  Total (6/10) (1/10) (3/10)
AdIL12–B7-1 1 0 1 0 4
(2.5 × 107) 2 1 1 0 3
3 0 3 0 7
 Total (1/20) (5/20) (14/20)
AdIL12–B7-1 1 0 3 2 0
(1 × 107) 2 0 2 3 0
 Total (5/10) (5/10)
AdIL12–B7-1 1 0 0 0 5
(1 × 108) 2 0 0 1 4
 Total (1/10) (9/10)
*

Tumor development following injection not significantly different from mice treated with control Addl70-3. 

†

Slight decrease in tumor volume and/or tumor growth significantly delayed and animals survived 2-8 weeks longer than controls. 

‡

Tumors completely regressed for at least 2 weeks. 

§

Tumors completely regressed and did not reoccur.